English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Kathy Adams | Sep 30, 2017

Pew award to help NYU School of Medicine team in neuroscience, immunology research

+ Community
Kathy Adams | Sep 30, 2017

Precision Medicine Group launches health industry client services unit

+ Technology/Innovation
Carol Ostrow | Sep 30, 2017

Joint study indicates exenatide safe for diabetics

+ Community
Carrie Bradon | Sep 30, 2017

Janssen teaming up with Department of Health and Human Services to prevent flu outbreaks

+ Community
Kathy Adams | Sep 30, 2017

Wake Forest Baptist Medical Center nurse anesthesia program turns 75

+ Community
Carol Ostrow | Sep 30, 2017

Economist study indicates lack of routine stroke screening

+ Community
Carol Ostrow | Sep 29, 2017

CSL Behring pledges $4.92 million for Penn State biotechnology center

+ Community
Carrie Bradon | Sep 29, 2017

Ongoing study of workers exposed to chemicals used to clean up oil spill finds many experience health issues

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

  • « First
  • «
  • …
  • 365
  • 366
  • 367
  • 368
  • 369
  • 370
  • 371
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily